Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β-Reference-Cited by-同舟云学术

Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β

Published:2018-01 Issue: Volume:412 Page:289-296
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Liu Rui-Min,Sun Dan-Ni,Jiao Ye-Lin,Wang Pan,Zhang Juan,Wang Ming,Ma Jin,Sun Man,Gu Bian-Li,Chen Pan,Liu Ke,Ma Heng,Gao She-Gan,Ma Yuan-Fang,Qi Yi-Jun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Inflammation and cancer: back to Virchow?;Balkwill;Lancet,2001

2. Inflammation and cancer;Coussens;Nature,2002

3. Inflammation and cancer: macrophage migration inhibitory factor (MIF)–the potential missing link;Conroy;QJM,2010

4. Cytokines as a key component of cancer-related inflammation;Germano;Cytokine,2008

5. Circulating inflammation markers, risk of lung cancer, and utility for risk stratification;Shiels;J. Natl. Cancer Inst.,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities;International Journal of Molecular Sciences;2024-04-29

2. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization;Journal of Experimental & Clinical Cancer Research;2024-04-29

3. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization;2023-11-08

4. The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma;Translational Oncology;2023-11

5. Research on essential performance of oxidized chitosan-crosslinked acellular porcine aorta modified with bioactive SCPP/DOPA for esophageal scaffold with enhanced mechanical strength, biocompatibility and anti-inflammatory;International Journal of Biological Macromolecules;2023-06